Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine.

Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research ·Vol. 16 ·No. 3 ·1971-03-00 ·Pages 216-24

Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Hayat M, de Vassal F, Jasmin C, Rosenfeld C, Pouillart P

Abstract

暂无摘要

MeSH Terms

Adolescent Adult Age Factors Aged Amantadine/administration & dosage Asparaginase/administration & dosage BCG Vaccine Child Child, Preschool Cytarabine/administration & dosage Humans Hydrocortisone/administration & dosage Immunity, Active Immunization, Passive Immunotherapy Infant Leucovorin/administration & dosage Leukemia, Lymphoid/drug therapy,radiotherapy,therapy Mercaptopurine/administration & dosage Methotrexate/administration & dosage Middle Aged Prednisone/administration & dosage Radiotherapy, High-Energy Remission, Spontaneous Vincristine/administration & dosage

Chemicals

BCG Vaccine Cytarabine Vincristine Amantadine Mercaptopurine Asparaginase Leucovorin Prednisone Hydrocortisone Methotrexate

Authors & Affiliations

9 authors, click to expand affiliations / ORCID

Mathé G

Amiel J L

Schwarzenberg L

Schneider M

Hayat M

de Vassal F

Jasmin C

Rosenfeld C

Pouillart P

Article Info

Journal

Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research

Abbr.

Rev Eur Etud Clin Biol

ISSN

0035-3019

Published

1971-03-00

Pages

216-24

Language

English

Region

France

NLM ID

0351323

Subset

External Links

PubMed source

Analysis Services

Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine.

Contact

WeChat Official Account